Results 51 to 60 of about 2,018,519 (298)
Consumer perception of private label brands in the Czech Republic
Littera Scripta, 2011 The very tough fight for customers in the retail trade is reflected by the strong growth in the number of products sold under private labels that are currently becoming an important factor in business competitiveness.
Věra Mulačová, Petr Mulač
doaj
Ouverture de 'Over-Supply and Global Markets – 2'
Symphonya, 2005 Globalisation and over-supplied markets impose new behaviour to achieve stable performance, with corporate strategies based on: downsizing, networking, merging, development of intangibles.
Silvio M. Brondoni
doaj +1 more source
microRNA‐7‐5p and α‐Synuclein SAA Predict Parkinson's Disease Phenoconversion
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Corroborate blood neuron‐derived extracellular vesicle (NDEV) alpha‐synuclein (αSyn), the CSF αSyn seed amplification assay (αSyn‐SAA), and blood microRNA‐7‐5p (miR‐7‐5p) as markers for Parkinson's disease (PD) phenoconversion and determine if combining these markers would help select subjects who would be more likely to phenoconvert.
Shayan Zadegan +4 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks +8 more
wiley +1 more source
The Evolution of Sustainability Perceptions in Mass-Market Products
Symphonya, 2015 Planet Life Economy Foundation (PLEF) is an Italian non-profit organization constituted in 2003 by managers and entrepreneurs from the mass-market industry.
Emanuele Plata
doaj +1 more source
The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD). Methods We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A)
Fausto Roveta +11 more
wiley +1 more source
Chain store management through private labels strategy
Tržište, 2007 The purpose of this paper is to examine the market shares of private labels in the European Union and on the global market, and to compare the results of the analysis with the level of presence of private labels on the Croatian market.
Martina Sopta
doaj
Fairtrade products in retail chains: Case study in the Czech Republic
Entrepreneurship and Sustainability Issues, 2023 The main objective of the article was to find out what the situation is with Fairtrade products on the Czech and Slovak markets in relation to consumed primary raw materials and their Fairtrade epremium, and also the supply of these products in retail ...
Alena Srbová, Nikola Sagapova
doaj +1 more source
Private label vriend of vijand?
Tijdschrift voor Marketing, 1997 Contains fulltext : 24705.PDF (Publisher’s version ) (Open Access)
Verhoef, P.C. +2 more
openaire +2 more sources
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source